For example, Tim-3 on ECs, by binding to a putative receptor on B16 tumor cells, resulting in NF-κB activation, Bcl-2 and Bcl-xL upregulation, and Bax downregulation, which finally leads to tumor cell resistance to apoptosis. The gene discussed is BCL2L1; the disease is neoplasm.